Effectiveness of nirmatrelvir plus ritonavir treatment for patients with chronic lymphocytic leukemia during the Omicron surge

Patients with chronic lymphoid leukemia (CLL), even in the Omicron era and after vaccination, suffer from persistent COVID-19 infection, higher complications, and mortality compared with the general population. In this study, we evaluated retrospectively the effectiveness of nirmatrelvir + ritonavir...

Descripción completa

Detalles Bibliográficos
Autores principales: Tadmor, Tamar, Alapi, Hilel, Rokach, Lior
Formato: Online Artículo Texto
Lenguaje:English
Publicado: by The American Society of Hematology 2023
Materias:
Lymphoid Neoplasia
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158583/
https://www.ncbi.nlm.nih.gov/pubmed/36848657
http://dx.doi.org/10.1182/blood.2022019017

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158583/
https://www.ncbi.nlm.nih.gov/pubmed/36848657
http://dx.doi.org/10.1182/blood.2022019017

Ejemplares similares